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Abstract
Introduction: The specific burden imposed on Intensive Care Units (ICUs) during the A/H1N1 influenza 2009
pandemic has been poorly explored. An on-line screening registry allowed a daily report of ICU beds occupancy
rate by flu infected patients (Flu-OR) admitted in French ICUs.
Methods: We conducted a prospective inception cohort study with results of an on-line screening registry
designed for daily assessment of ICU burden.
Results: Among the 108 centers participating to the French H1N1 research network on mechanical ventilation
(REVA) - French Society of Intensive Care (SRLF) registry, 69 ICUs belonging to seven large geographical areas
voluntarily participated in a website screening-registry. The aim was to daily assess the ICU beds occupancy rate by
influenza-infected and non-infected patients for at least three weeks. Three hundred ninety-one critically ill infected
patients were enrolled in the cohort, representing a subset of 35% of the whole French 2009 pandemic cohort;
73% were mechanically ventilated, 13% required extra corporal membrane oxygenation (ECMO) and 22% died. The
global Flu-OR in these ICUs was only 7.6%, but it exceeded a predefined 15% critical threshold in 32 ICUs for a
total of 103 weeks. Flu-ORs were significantly higher in University than in non-University hospitals. The peak ICU
burden was poorly predicted by observations obtained at the level of large geographical areas.
Conclusions: The peak Flu-OR during the pandemic significantly exceeded a 15% critical threshold in almost half
of the ICUs, with an uneven distribution with time, geographical areas and between University and non-University
hospitals. An on-line assessment of Flu-OR via a simple dedicated registry may contribute to better match
resources and needs.
Introduction
In the fall of 2009, the reported incidence of patients
infected with the pandemic influenza A(H1N1) virus in
France exceeded the usual incidence of seasonal flu
[1,2]. Notification of all patients infected with A(H1N1)
virus became mandatory from 1 July to 2 November
2009 but later was restricted to intensive care unit
(ICU) admissions because of a large and rapid increase
in the number of cases [3].
Taking into account observations made during the
early stage of the pandemic in other countries [4-6]
(especially in the Southern hemisphere [7-11]), the
French Ministry of Health organized the response to the
pandemic according to the possible needs of seven
regions, so-called ‘defense areas’, in order to regulate the
supply of equipment (Figure 1). The purpose of this
plan was to distribute resources equitably across regions
while avoiding any shortage in ICU beds. Extracorporal
membrane oxygenation (ECMO) devices and ICU venti-
lators were distributed in the reference centers of each
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defense area to cover the French territory. A 15% rate of
ICU bed occupancy by flu patients in a region was indi-
cated as a critical threshold to consider cancellation of
scheduled surgical activities.
At the same time, we recorded data corresponding to
the cohort of ICU patients through a large research net-
work on mechanical ventilation (REVA-SRLF registry)
[12]. In addition, we designed a dedicated website screen-
ing registry to prospectively assess the specific burden
related to the A(H1N1) pandemic in ICUs recruited on a
voluntary basis. We proposed that a relatively simple
screening registry would be able to give a much more
exact picture of the respective burden on the different
ICUs, geographical areas, and university versus non-uni-
versity centers. Here, we report the exact rate of ICU bed
occupancy by flu-infected patients (Flu-OR) during the
pandemic in a representative subset of French ICUs.
Materials and methods
The French REVA-SRLF registry was a multi-center pro-
spective observational survey based on a website registry,
and several results of this registry have been published
elsewhere [13-15]. In brief, from November 2009 (week
09-45) through January 2010 (week 10-03), 89 out of 108
ICUs participating in the general registry (representing
one fourth of all French ICUs) accepted an invitation to
participate in a website screening registry to do a daily
assessment of the rate of ICU bed occupancy by influ-
enza-infected and non-infected patients. Sixty-nine ICUs
belonging to either referral university hospitals (31 ICUs)
or general hospitals (38 ICUs) eventually completed the
daily screening for at least three consecutive weeks and
admitted at least one A(H1N1)-infected patient and were
kept for the present analysis. Twenty ICUs that, for orga-
nization reasons or for lack of A(H1N1) patients, did not
Figure 1 Number of university and non-university hospitals participating in the study and total number of beds of participating
intensive care units in the seven ‘defense areas’.
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complete three consecutive weeks were excluded from
the analysis.
Recording of patients’ data in the registry was approved
by the national commission for protection of patients’
rights and electronic data recording. The study was
approved by the ethics committee of the French Society
of Intensive Care (SRLF). Informed consent was waived
in agreement with the observational design of the study.
Cohort study
Suspected infection was proven by means of a polymerase
chain reaction eventually completed by serologic analysis.
When positive, the patient was considered a ‘confirmed
case’. A typical clinical flu presentation associated with a
negative test was considered a ‘suspected case’ when no
other etiology was found. Suspected as well as confirmed
cases were enrolled in the present study. Admission data
consisted of dates and times of admission to the hospital
and ICU; age; sex; pregnancy status; fatal underlying dis-
ease defined within the McCabe [16] classification; the
Simplified Acute Physiology Score III (SAPS III) [17],
which is a severity score ranging from 0 to 217; immuno-
suppression and its cause; history of chronic respiratory
disease, diabetes, or chronic heart failure; weight and
height; and pregnancy. A follow-up during the ICU hospi-
talization, including time and duration of ventilation,
antiviral and corticosteroid use, use of rescue therapy
including ECMO, and the cause of death, was also
performed.
Specific screening registry
A specific website registry (screening registry) was
designed in order to do a daily assessment of the occu-
pancy rate related to the management of A(H1N1) non-
ventilated or ventilated patients.
Isn’t ‘in order to daily assess the occupancy rate...’ bet-
ter? Baseline information on the number of available
beds, ventilators, and staffing was collected. For each par-
ticipating unit, a customized table representing the num-
ber of available beds on each day of the week was
displayed on the website (Figure 2). Each available bed
was characterized by using a specific code on a daily
basis to identify whether it was occupied or used by a
non-infected patient or a flu-infected patient; the ventila-
tion status (mechanically ventilated or not) of each
patient was also coded. The number of available beds
could be modified each day in case of the closing or
opening of additional beds. Online completion of the reg-
istry required less than 30 minutes per day for a 20-bed
ICU and usually was performed every morning after
checking the patients’ status during the first round. To
facilitate postponed data recording, a table corresponding
to the week in progress was available on the website for
printing. The website was designed by a professional who
paid great attention to the user-friendliness of the inter-
face. Each participating center received a weekly electro-
nic update to provide information on the evolution of the
pandemic and encourage completion of the registry.
When needed, reminders were automatically displayed
on the website.
Based on these data, the ICU bed Flu-OR was computed
as the number of bed-days per week occupied by flu
patients divided by the total number of bed-days occupied
per week and was expressed as a percentage. A weekly
Flu-OR was calculated for each participating ICU and for
each defense area in the course of the pandemic, differen-
tiating ventilated from non-ventilated patients. We also
differentiated Flu-OR observed in university hospitals
from that in non-university hospitals.
Data collection and quality control assessment
Data collected were directly downloaded as electronic .xls
files from the REVA web registry. The data management
and the analysis were performed by CB-B, TP, and J-CMR.
The database was completed when needed after direct
contact with the ICU physicians. Duplicate notifications
were systematically checked, and patients transferred from
one participating ICU to another were counted as a single
admission.
Statistical analysis
Descriptive statistics included frequency analysis - per-
centages and corresponding 95% confidence intervals
(CIs) - for categorical variables and means and standard
deviations or medians and interquartile ranges (IQRs)
for continuous variables. Differences in medical and
demographic characteristics according to outcomes or
in Flu-OR between types of hospitals were tested by
using a chi-squared test for categorical variables and a
Student t test for continuous parametric variables. All
statistical tests were two-sided, and P values of 0.05 or
less denoted statistical significance. Statistical analysis
was performed with R software packages [18].
Results
Cohort study
Three hundred ninety-one patients with A(H1N1) were
admitted from 26 September 2009 to 10 February 2010
in the 69 ICUs participating in the screening registry and
were included in this study. Among them, 349 (89%) had
a confirmed influenza A infection. This subset of 391
patients represents 36.7% of the whole cohort of French
influenza-infected adult ICU patients [3]; they had the
same overall characteristics, except for a higher rate of
immunosuppression (Table 1). Tables 2 and 3 show the
baseline characteristics and main risk factors for flu
recorded in these patients according to survival or to the
intensity of ventilatory support. Mechanical ventilation
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was provided to 286 (73%) patients, 231 (59%) fulfilled
criteria for acute respiratory distress syndrome, and 50
(13%) required additional ECMO. The mortality rate of
the whole cohort was 22%.
Screening registry
Figure 1 shows the distribution of the 69 ICUs partici-
pating in the screening registry across the seven defense
areas as well as the distribution of ICU beds belonging
Figure 2 Original version of the online registry page dedicated to the screening study for an intensive care unit (ICU) of 10 beds. Each
column represents a day of the week, and each line represents a bed of this ICU. Each box of this table gives the birth date and status of the
patient occupying this particular bed on this particular day. F, flu; MV, mechanical ventilation; NF, non-flu; SB, spontaneous breathing; 0,
unoccupied bed.
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to university and non-university hospitals. The median
number of beds per ICU (including intermediate-care
beds) was 15 (IQR of 12 to 21), representing a total of
942 ICU beds and 220 intermediate-care beds.
Figure 3 shows the weekly and maximal Flu-OR in the
seven defense areas. The peak of the pandemics varied
across the different geographical defense areas as illu-
strated by the profiles of the mean Flu-OR in each region
(Figure 3). The maximal Flu-OR observed in any ICU in
each region is also indicated. A Flu-OR of above 15% was
recorded in 32 individual ICUs, for a total of 103 weeks
out of the accumulated 623 weeks of screening across the
69 ICUs: 16.5% of the screening weeks (95% CI of 13.6%
to 19.4%). The percentage of screened weeks with Flu-OR
of above 15% varied between defense areas from 8.5%
(east) to 34.3% (north).
The pooled Flu-OR calculated over the whole study
period (including university and non-university hospital)
for the entire country was 7.6% and varied across the
seven defense areas from 6.1% (east) to 10.5% (south-
east). At each week, this rate was significantly higher in
university hospitals than in non-university hospitals
(Figure 4). During the pandemic period, none of the
participating hospitals used the threshold level of 15%
ICU bed occupancy rate to modify hospital admission
policy or bed availability.
Discussion
In this prospective observational study using a dedicated
online screening registry designed to assess the daily bur-
den of the A(H1N1) influenza pandemic on French ICUs,
we found important variations in the actual influenza
burden between geographical areas, university and non-
university hospitals, and time. In several individual ICUs,
our screening registry has permitted us to observe peak
occupancy rates greatly exceeding those calculated by
averaging data observed in the largest defense areas. Our
findings suggest that the organization of future pandemic
response plans can greatly benefit from online data
obtained in almost real time [19,20]. A dedicated online
registry able to assess the week-by-week Flu-OR in each
ICU may help to better distribute resources according to
the actual needs. Even if ICUs were encouraged to do a
daily assessment of the presence of patients with A
(H1N1), we chose to report the calculation per week first
to be consistent with the French organization and the
National Institute for Public Health Surveillance
(NIPHS), which displayed the time course of the pan-
demic weekly, and also to simplify data notification for
participating centers. In fact, in collaboration with the
NIPHS, we developed a strong communication strategy
via the REVA website to simplify and therefore encou-
rage rigorous notification.
Flu-ORs calculated per week in the present study were
comparable to and often higher than those observed in
the Southern hemisphere. Over the 3-month pandemic
period in Australia and New Zealand [11], the ANZICS
(Australian and New Zealand Intensive Care Society)
investigators reported that an average of 5.2% of available
ICU bed-days were occupied by patients with H1N1
infection, whereas the peak percentage ranged from 8.9%
to 19% [11]. In our study, 7.6% of the beds of enrolled
ICUs were occupied by influenza-infected patients during
the whole study period, and a maximum Flu-OR
recorded per week in individual ICUs reached 35%.
Inclusion of the 10 ICUs that had not admitted any
patients with A(H1N1) would have lowered global Flu-
OR but would not have changed the maximal Flu-ORs
Table 1 Characteristics of the patients reported to the
national health surveillance system [3] and the subgroup
included in the screening study
Baseline characteristics Screening cohort
(n = 391)
NIPHS
(n = 1,065)
Age in years 46 (33-57) 49 (35-58)
Male 210 (53%) 562 (53%)
No risk factor of complication 87 (22%) 191 (18%)
Immunosuppression 89 (23%) 82 (8%)
Asthma 46 (12%) 135 (13%)
Chronic obstructive pulmonary disease 77 (20%) 214 (20%)
Chronic heart failure 33 (8%) 84 (8%)
Diabetes 53 (13%) 125 (12%)
Obesity: body mass index > 30 115 (29%) 84 (27%)
Pregnancy 18 (4.6%) 58 (6%)
Death 87 (22.2%) 217 (20.4%)
Except for ‘Age in years’, which is expressed as mean (interquartile range),
values are expressed as number (percentage). NIPHS, National Institute for
Public Health Surveillance.
Table 2 Baseline characteristics and comparison of
survivors with the deceased
Baseline characteristics Survivors
(n = 304)
Deceased
(n = 87)
P value
Age in years 45 (16) 50 (17) 0.01
Male 159 (52%) 51 (59%) 0.35
McCabe 1 241 (79%) 50 (57%) < 10-4
McCabe 2 or 3 63 (21%) 37 (42%) < 10-4
No risk factor of complication 68 (22%) 19 (22%) 0.97
Immunosuppression 51 (17%) 38 (44%) < 10-4
Asthma 46 (15%) 0 (0%) < 10-4
Chronic obstructive pulmonary disease 61 (20%) 16 (18%) 0.84
Chronic heart failure 26 (9%) 7 (8%) 0.94
Diabetes 40 (13%) 13 (15%) 0.80
Obesity: body mass index > 30 86 (28%) 29 (33%) 0.43
Pregnancy 17 (6%) 1 (1%) 0.14
Except for ‘Age in years’, which is expressed as mean (standard deviation),
and P values, values are expressed as number (percentage). McCabe 1 = no or
non-fatal underlying disease; McCabe 2 = ultimately fatal disease (< 5 years);
McCabe 3 = rapidly fatal disease (< 1 year).
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that we observed. The ICU length of stay, however, may
have impacted the Flu-OR since a large difference
between the two reports was observed: the median dura-
tions of ICU stay were 7.4 days (IQR of 3 to 16) in the
ANZICS study and 10 days (IQR of 5 to 24) in French
ICUs. Uneven time and regional distribution may also
impact the Flu-OR calculations.
In the ANZICS investigation, the number of days that
ICU beds were occupied by infected patients per region
was calculated by multiplying the total number of patients
by their length of stay. This approach allowed us to esti-
mate a peak Flu-OR per region but not per individual
ICU. The results of our registry show that this can greatly
underestimate true peak activities in some ICUs. This is of
particular importance since H1N1 burden changed rapidly
over time and from one ICU to the other. The web-based
screening registry specifically developed for our study
allowed a daily assessment of the ICU occupancy rate in
individual ICUs with an accuracy similar to that in larger
regions. For example, observations reported from the Paris
area (Figure 3) showed that the maximal Flu-OR signifi-
cantly differed from the weekly Flu-OR calculated within
all ICUs belonging to that region. Overall, our observa-
tions suggest that an accurate estimation of the influenza
burden on ICUs requires a daily and real-time Flu-OR
assessment, which seems feasible in view of our findings.
In anticipation of the flu surge, health authorities
decided that, in order to alleviate the pressure on ICU
beds, planned surgery activity should be cancelled when
Flu-OR exceeded 15%. We contacted each participating
ICU and confirmed that no canceling of scheduled surgery
had been decided although Flu-OR exceeded 15% in many
ICUs. Such peak activities occurred for more than 103
weeks among 32 units. Future analysis may help to refine
this threshold and thus may have to take into account
how long it is exceeded. The magnitude of a pandemic
and its consequences on the organization of a health-care
system depend on several parameters and are notoriously
difficult to predict [21,22]. Therefore, experiences reported
during the first waves throughout the world were useful to
better elaborate forecasts taking into account different
attack rates and epidemic wave durations [23,24]. Data
gathered in Canada during the first wave were applied to a
variety of second-wave models to determine its impact on
ICU and ventilator demand [21,25]. An attack rate of
greater than 20% can result in significant shortages in ICU
beds and ventilators [21]. Retrospective estimations
showed that attack rates in Europe [26], North America,
and Australia did not exceed 10% during each of the 2009
pandemic waves [27]. The overall impact also greatly
depends on the durations of mechanical ventilation and
ICU stay. High attack rate combined with a short epidemic
duration and long expected duration of mechanical venti-
lation represents the worst scenario in terms of bed occu-
pancy rate and thus the maximal burden. Given a 20%
attack rate with a similar clinical presentation, French ICU
resources in university hospitals would probably have been
overwhelmed, according to our observations.
A weakness of our study is that only a subset of French
ICUs participated in the screening. Our cohort repre-
sented 35% of the whole French cohort reported during
the same period to the health ministry. The distribution of
the subset of university and non-university hospitals parti-
cipating in this study within the seven areas (except in the
northern area) suggests that French ICU health-care
resources were reasonably well represented (Figure 1).
This is supported by the comparability of baseline charac-
teristics of patients within the present cohort to those of
the entire French cohort (Table 1) [3].
General inferences that can be made from this study
are limited because of the difficulties in extrapolating
from one health-care system to another. But regardless of
the system, the primary goal here was to be able to assess,
as closely to reality as possible, the related burden of an
epidemic, and such an assessment was made possible by
the specific screening registry.
Conclusions
Revisiting the pandemic plans in light of emergent find-
ings is certainly a key issue to be able to cope with
further pandemic waves. Our observations suggest that
the specific activity related to critically ill H1N1-infected
Table 3 Baseline characteristics and clinical course according to intensity of ventilatory support
Baseline characteristics Total No mechanical
ventilation
Mechanical ventilation without ARDS ARDS
without ECMO
ECMO
Number of patients (percentage) 391 105 (27%) 55 (14%) 181 (46%) 50 (13%)
Age in years, mean (SD) 46 (16) 40 (16) 52 (18) 48 (15) 37 (12)
SAPS III, mean (SD) 52 (17) 41 (13) 53 (14) 56.5 (17) 58.3 (17)
Duration of ventilation in days, median (IQR) 12 (5-24) 0 2 (4-10) 13 (7-21) 26 (12-37)
Length of stay in ICU in days, median (IQR) 10 (5-24) 4 (3-6) 8 (5-16) 17 (9-27) 26 (14-42)
Obesity, number (percentage) 115 (29%) 20 (19%) 16 (21%) 60 (33%) 23 (46%)
Mortality, number (percentage) 87 (22.2%) 2 (1.9%) 7 (12%) 56 (30.1%) 22 (44%)
ARDS, acute respiratory distress syndrome; ECMO, extracorporal membrane oxygenation; ICU, intensive care unit; IQR, interquartile range; SAPS III, Simplified
Acute Physiology Score III; SD, standard deviation.
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Figure 3 Rate of intensive care unit (ICU) bed occupancy by flu-infected patients in the seven ‘defense areas’. For each defense area,
the table shows the weekly occupancy rate (from week 45 of 2009 to week 3 of 2010) according to the type of ICU (university or non-
university) and the rate of ventilated and non-ventilated patients. The black marks indicate the maximal occupancy rate of an ICU of this area.
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patients varied widely according to time, regions, and
individual ICUs as well as within larger areas. We report
maximal ICU Flu-ORs that significantly exceed the 15%
predefined critical threshold. The website registry
described here and tested during the first pandemic wave
in France allowed a real-time awareness of bed utilization
and capacity.
Key messages
• A simple online registry permits us to accurately
describe specific H1N1 ICU burden in real time.
• ICU burden related to H1N1-infected patients var-
ied widely according to time, regions, and individual
ICUs.
• In most ICUs, the maximal rate of bed occupancy
by patients with flu exceeded the predefined 15% cri-
tical threshold.
• Online assessment of Flu-OR in the ICU may help
to better match resources and needs in case of new
H1N1 pandemics.
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